| Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic … SL James, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1789-1858, 2018 | 14334* | 2018 |
| Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 T Vos, SS Lim, C Abbafati, KM Abbas, M Abbasi, M Abbasifard, ... The lancet 396 (10258), 1204-1222, 2020 | 7474 | 2020 |
| Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and … JD Stanaway, A Afshin, E Gakidou, SS Lim, D Abate, KH Abate, ... The Lancet 392 (10159), 1923-1994, 2018 | 7261* | 2018 |
| Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990 … HH Kyu, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1859-1922, 2018 | 6244* | 2018 |
| Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 CJL Murray, AY Aravkin, P Zheng, C Abbafati, KM Abbas, ... The lancet 396 (10258), 1223-1249, 2020 | 5743 | 2020 |
| Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the … T Vos, AA Abajobir, KH Abate, C Abbafati, KM Abbas, F Abd-Allah, ... The Lancet 390 (10100), 1211-1259, 2017 | 5662 | 2017 |
| Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis … JD Steinmetz, RRA Bourne, PS Briant, SR Flaxman, HRB Taylor, ... The Lancet Global Health 9 (2), e144-e160, 2021 | 1345 | 2021 |
| Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic … H Wang, KM Abbas, M Abbasifard, M Abbasi-Kangevari, H Abbastabar, ... The Lancet 396 (10258), 1160-1203, 2020 | 1236 | 2020 |
| Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the … NJ Kassebaum, M Arora, RM Barber, ZA Bhutta, J Brown, A Carter, ... The Lancet 388 (10053), 1603-1658, 2016 | 1046 | 2016 |
| Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 C Abbafati, DB Machado, B Cislaghi, OM Salman, M Karanikolos, ... Deakin University, 2020 | 1033 | 2020 |
| Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 D Dicker, G Nguyen, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 1684-1735, 2018 | 972 | 2018 |
| Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study R Bourne, JD Steinmetz, S Flaxman, PS Briant, HR Taylor, S Resnikoff, ... The Lancet global health 9 (2), e130-e143, 2021 | 675 | 2021 |
| Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015 SS Lim, K Allen, ZA Bhutta, L Dandona, MH Forouzanfar, N Fullman, ... The Lancet 388 (10053), 1813-1850, 2016 | 666 | 2016 |
| Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic … R Lozano, N Fullman, D Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 2091-2138, 2018 | 505 | 2018 |
| Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global … N Fullman, RM Barber, AA Abajobir, KH Abate, C Abbafati, KM Abbas, ... The Lancet 390 (10100), 1423-1459, 2017 | 410 | 2017 |
| Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema M Soheilian, A Ramezani, A Obudi, B Bijanzadeh, M Salehipour, M Yaseri, ... Ophthalmology 116 (6), 1142-1150, 2009 | 315 | 2009 |
| Anatomic and visual outcomes of scleral buckling versus primary vitrectomy in pseudophakic and aphakic retinal detachment: six-month follow-up results of a single operation … H Ahmadieh, S Moradian, H Faghihi, MM Parvaresh, H Ghanbari, ... Ophthalmology 112 (8), 1421-1429, 2005 | 249 | 2005 |
| Early detection of diabetic retinopathy H Safi, S Safi, A Hafezi-Moghadam, H Ahmadieh Survey of ophthalmology 63 (5), 601-608, 2018 | 218 | 2018 |
| Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial H Ahmadieh, N Shoeibi, M Entezari, R Monshizadeh Ophthalmology 116 (10), 1943-1948, 2009 | 217 | 2009 |
| Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial H Ahmadieh, A Ramezani, N Shoeibi, B Bijanzadeh, A Tabatabaei, ... Graefe's Archive for Clinical and Experimental Ophthalmology 246, 483-489, 2008 | 210 | 2008 |
